»ýÁãÀÇ ¹ÙÀÌ·¯½º¼º ½É±Ù¿°¿¡¼ ÇÕº´Áõ µ¿¹Ý À¯¹«¿¡ µû¸¥ Á¶Á÷ ¹× Ç÷û³» ±Ý¼Ó´Ü¹éÈ¿¼Ò¾ïÁ¦ÀÚÀÇ ¹ßÇö Â÷ÀÌ
Altered Expression of Tissue Inhibitor of Matrix Metalloproteinase-2 in Complicated Mice Heart Secondary to Experimentally Induced Viral Myocarditis
±è¼º¼÷, ¾ö´ë¿î, ¼ÀçÈñ, ÇãÁÖ·É, È«¿µ¹Ì, ÃÖÀÎÇ¥,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¼º¼÷ ( Kim Sung-Sook )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¾ö´ë¿î ( Eom Dae-Woon )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¼ÀçÈñ ( Suh Jae-Hee )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÇãÁÖ·É ( Huh Joo-Ryung )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
È«¿µ¹Ì ( Hong Young-Mi )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ÃÖÀÎÇ¥ ( Choi In-Pyo )
Çѱ¹»ý¸í°øÇבּ¸¿ø ºÐÀÚ»ýÀÇÇבּ¸½Ç
KMID : 0357920010350030196
Abstract
Background: The pathogenesis of transition from viral myocarditis to dilated cardiomyopathy is elusive, although the incidence of dilated cardiomyopathy in human is increasing.
Methods: To clarify the role of the tissue inhibitor of matrix metaloproteinase-2 (TIMP-2) in this event, we performed immunohistochemistry, immunoblotting and immunoassay of matrix metalloproteinase-9 (MMP-9) and TIMP-2 in the serum and heart tissue of mice, which were inoculated with 4000 plaque-forming units of coxsackie B virus.
Results: The MMP-9 was expressed in damaged cardiomyocytes, and the TIMP-2 was expressed in mainly interstitial connective tissue between cardiac muscle bundles by immunohistochemistry. The level of serum MMP-9 was higher in the complicated than non-complicated group (p<0.001), but the level of TIMP-2 was much lower in complicated than non-complicated group (p<0.05). These findings were similar to the results of immunohistochemistry and immunoblotting in tissues.
Conclusions: These results suggest that an imbalance in the level of MMP-9 and its inhibitor might activate cardiac complication in viral myocarditis.
Å°¿öµå
Myocarditis;Cardiomyopathy;Gelatinase B;Tissue inhibitor of matrix metalloproteinase-2;Immunohistochemistry
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸